PATENT CLAIM ANALYSIS

Application Number: 16069487
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Claim (Index 63):
The method of  claim 44 , wherein the antibody or fragment thereof comprises a heavy chain variable region comprising an amino acid sequence selected from the group consisting of SEQ ID NO:238, 246-259, 261, 263, 265, 267, 269, 271, 273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293, 295, 297, 299, 301, 303, 305, 307, 309, 311, 313, 315, 317, 319, 321, 323, 325, 327, 329, 331, 333, 335, and 337.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.17143
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15166305', '15254315', '15636610', '14472116', '15211504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6738572770383323
- 35 USC 102 Novelty (BERT): 0.543649479645001
- Combined Prediction Score: 0.6608364972989992
- Mean Citation Score: 363.044838
- Max Citation Score: 381.17462
- Similarity Product: 312.80237949454187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test